NCT00141245

To Evaluate Long-Term Safety and Efficacy of Pregabalin in Patients With Partial Seizures.

Pregabalin Open-Label, Multicenter Add-On Trial Following a 4-Day Double-Blind Transition Period to Determine Long-Term Safety and Efficacy in Patients With Partial Seizures.

• Status: Completed
• Phase: Phase 3
• Study type: Interventional
• Enrollment: 325 (planned)
• Sponsor: Pfizer · Industry
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

To evaluate long-term safety and efficacy of pregabalin in patients with partial seizures.

Conditions

• Seizure Disorder, Partial

Interventions

Type	Name	Description
DRUG	Pregabalin

Timeline

• Start date: 1998-10-01
• Completion: 2005-11-01
• First posted: 2005-09-01
• Last updated: 2007-01-01

Locations

46 sites across 13 countries: Australia, Austria, Belgium, Finland, France, Germany, Italy, Netherlands, South Africa, Spain, Sweden, Switzerland, United Kingdom